Miriam M. Yeung - Concepedia

Concepedia

Author

Miriam M. Yeung

Peter MacCallum Cancer Centre ORCID

Also Known As

M. Yeung, Miriam M Yeung, Miriam M. Yeung, Miriam Manning Yeung, Miriam Yeung, Ms Aria HL Yeung, Yeung, Miriam

43

Publications

1.2K

Citations

9

H-Index

22

Concepts

All Affiliations

Peter MacCallum Cancer Centre The University of Melbourne Monash University GlaxoSmithKline (United States)Walter and Eliza Hall Institute of Medical Research

MM

About

Miriam M. Yeung is an author at Peter MacCallum Cancer Centre specializing in medicine, cell biology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	345
2	Cell Biology	2	2	214
3	Health Sciences	1	1	170
4	Allergy	1	1	33
5	Allergy Medicine	1	1	33

Miriam M. Yeung

×

9

Publications

1.2K

Citations

9

H-Index

	Year	Citations
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation Omer Gilan, Inmaculada Rioja, Kathy Knezevic, Science	2020	411
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia Charles C. Bell, Katie Fennell, Yih-Chih Chan, Nature Communications	2019	175
HBO1 is required for the maintenance of leukaemia stem cells Laura MacPherson, Juliana Anokye, Miriam M. Yeung, Nature MedicineStem Cell MobilizationLeukaemia Stem CellsStem Cell ResearchStem-cell Therapy	2019	170
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2–Positive Metastatic Breast Cancer Sheau Wen Lok, James R. Whittle, François Vaillant, Cancer Discovery	2019	143
HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults Nila J. Dharan, Paul Yeh, Mark Bloch, Nature Medicine Sexual HealthAge-related Clonal HematopoiesisHuman RetrovirusHematologyChronic Viral Infection	2021	98
Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study Peter Savas, Louisa L. Lo, Stephen J. Luen, Cancer Discovery	2022	52
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses Kah Lok Chan, Juliana Gomez, Chelisa Cardinez, Cancer Cell Cancer ImmunosurveillanceImmunologyTumor ImmunityImmunologic MechanismAnti-cancer Immune Responses	2022	44
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study Andjelija Zivanovic Bujak, Chen-Fang Weng, Maria João Silva, PLoS Medicine	2020	34
A 3-month evaluation of the efficacy of nedocromil sodium in asthma: A randomized, double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicenter study group A. S. Rebuck, Steven Kesten, L.‐P. Boulet, Journal of Allergy and Clinical Immunology Asthma3-Month EvaluationAllergyAllergy MedicinePharmacology	1990	33

Page 1